EBITDA Margin % is calculated as EBITDA divided by its Revenue. CodeLab Capital AS's EBITDA for the
six
months ended in Dec. 2025 was €-0.46 Mil. CodeLab Capital AS's Revenue for the
six
months ended in Dec. 2025 was €1.05 Mil. Therefore, CodeLab Capital AS's EBITDA margin for the quarter that ended in Dec. 2025 was -43.62%.
CodeLab Capital AS (FRA:P990) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
CodeLab Capital AS EBITDA Margin % Related Terms
CodeLab Capital AS EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for CodeLab Capital AS's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:P990 vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, CodeLab Capital AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CodeLab Capital AS EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CodeLab Capital AS's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where CodeLab Capital AS's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CodeLab Capital AS (FRA:P990) has a EBITDA Margin % of -43.62% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CodeLab Capital AS and its competitors. According to the industry distribution chart, CodeLab Capital AS ranks #609 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 91.2%.
Is CodeLab Capital AS's EBITDA Margin % too high?
CodeLab Capital AS's current EBITDA Margin % is -43.62%. Based on the distribution chart, CodeLab Capital AS ranks #609 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, CodeLab Capital AS has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does CodeLab Capital AS's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CodeLab Capital AS ranks #609 out of 668 companies for EBITDA Margin %. This places CodeLab Capital AS in the lower half of its industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CodeLab Capital AS and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CodeLab Capital AS's current EBITDA Margin % is -43.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CodeLab Capital AS stock overvalued right now?
CodeLab Capital AS (FRA:P990) has a current EBITDA Margin % of -43.62%. The stock's GF Value™ is €0.20, compared to a current price of €0.25 — trading 24% above its estimated fair value. The current EBITDA Margin % is -43.62%. CodeLab Capital AS's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For CodeLab Capital AS (FRA:P990), the current EBITDA Margin % is -43.62% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CodeLab Capital AS (FRA:P990) Overvalued in 2026?
Based on GuruFocus' analysis, CodeLab Capital AS stock appears to be overvalued.
The current stock price of €0.25 is trading 24% above its estimated GF Value™ of €0.20.
Key valuation signals for FRA:P990:
EBITDA Margin %: -43.62%
GF Value™: €0.20 vs. price of €0.25 (24% above fair value)
No single metric tells the full story. See the FRA:P990 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CodeLab Capital AS builds and invests in next-generation technology. Its primary objective is to invest in other companies and contribute with capital, network, and operations. CodeLab Capital AS is a holding company that, through its subsidiary, is engaged in making software development tools for the broader B2B market.
55GF Score
Get the complete analysis for FRA:P990
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:P990 has been successfully added to your 
